Newly emerging pathogens including bacterial pathogens with emerging resistance to current antimicrobial agents pose a major public health problem globally. There is an urgent need for more trans-disciplinary and trans-sectorial approaches to prioritize and tackle this emerging public health problem.
Performance Contracting 2021/2022 at UoN
It seems a lifetime ago since I joined KAVI as a scrawny pimply young doctor on 12th January 2004. After working 7 years at a busy A/E department, I knew clinical practice wasn’t for me. I had tried my hand in ENT surgery but that didn’t work out either. Somewhat lost and disillusioned, I needed out but didn’t know what I wanted. Joining KAVI was a stepping stone to the unknown. Little did I know then that in KAVI I would find the true purpose of my career in medicine in the field of clinical research.
Dr. Marianne Mureithi presented KAVI-ICR ground-breaking Mucosal Immunology work titled “Defining HIV-1 interactions at the Mucosa” at the emerging techniques for investigating mucosal immunity and delivery of therapies symposium” held at the Anthony de Rothschild Lecture Theatre, St Mary’s Campus Imperial College London, UK on August 5th, 2019.
